Edgestream Partners’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.8M Buy
2025
Q1
Sell
2024
Q4
$2.38M Buy
2024
Q3
Sell
2024
Q2
$3.46M Buy
2022
Q1
Sell
2021
Q4
$3.64M Buy
2021
Q3
$1.71M Buy